A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.
Clinical trial NCT01969851 · COMPLETED
Trial details
- NCT number
- NCT01969851
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-13
- Primary completion
- 2018-04-10
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.